Proteins predicted to interact with GLP1R Predicted protein interactions based upon String database
A dose of 100 mcg daily for six or seven days should be administered by intramuscular or deep subcutaneous injection
Regular follow-up allows monitoring of both B12 levels and liver disease progression, with treatment adjustments as needed
Contact us today to schedule your consultation and take the first step towards a brighter, healthier tomorrow.
1 Zepbound (Tirzepatide 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) subcutaneous injections, Rx only, combined with a reduced-calorie diet and exercise helps to reduce excess body weight and maintain weight reduction in adults with obesity or overweight and at least one weight-related condition, as well as moderate to severe obstructive sleep apnea
"Mazdutide (IBI362), a GLP-1/glucagon receptor dual agonist, in Chinese adults with overweight or obesity: a randomised, placebo-controlled, multiple-ascending-dose phase 2 trial." EClinicalMedicine 59 (2023)
